14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of STOK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stoke Therapeutics, Inc. stock price ended at $11.94 on Tuesday, after gaining 0.590%.
(Updated on May 07, 2024)

Buy or Hold candidate since Mar 22, 2024 Gain 89.52% PDF

The Stoke Therapeutics, Inc. stock price gained 0.590% on the last trading day (Tuesday, 7th May 2024), rising from $11.87 to $11.94. During the last trading day the stock fluctuated 6.42% from a day low at $11.37 to a day high of $12.10. The price has risen in 7 of the last 10 days and is up by 6.13% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 8 thousand more shares were traded than the day before. In total, 617 thousand shares were bought and sold for approximately $7.36 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $10.66 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 95.04% during the next 3 months and, with a 90% probability hold a price between $20.78 and $35.60 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

STOK Signals & Forecast

The Stoke Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $11.71 and $11.37. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -15.74%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Stoke Therapeutics, Inc. stock

Stoke Therapeutics, Inc. finds support from accumulated volume at $11.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.730 between high and low, or 6.42%. For the last week, the stock has had daily average volatility of 6.64%.

Our recommended stop-loss: $11.23 (-5.96%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 28 days ago.)

Trading Expectations (STOK) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Stoke Therapeutics, Inc. to open at $11.80, and during the day (based on 14 day Average True Range), to move between $10.94 and $12.94, which gives a possible trading interval of +/-$1.00 (+/-8.37%) up or down from last closing price. If Stoke Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 16.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.66 (2.35%) than the resistance at $13.08 (9.55%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Stoke Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Stoke Therapeutics, Inc. stock to perform well in the short-term.

Current score: 3.559 Buy Candidate Unchanged

Predicted Opening Price for Stoke Therapeutics, Inc. of Wednesday, May 8, 2024

Fair opening price May 8, 2024 Current price
$11.80 ( 1.14%) $11.94

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for STOK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12.53 4.97 %
R2 12.25 2.63 %
R1 12.08 1.19 %
Current price: 11.94
Support S1 11.52 -3.48 %
S2 11.35 -4.92 %
S3 11.07 -7.26 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.17 18.68 %
R2 13.50 13.07 %
R1 13.08 9.55 %
Current price 11.94
Support S1 11.66 -2.35%
S2 11.25 -5.78%
S3 10.29 -13.82%

FAQ

What is the symbol for Stoke Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Stoke Therapeutics, Inc. is STOK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Stoke Therapeutics, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Stoke Therapeutics, Inc. stock to perform well in the short-term.

How to buy Stoke Therapeutics, Inc. Stock?
Stoke Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Stoke Therapeutics, Inc. Stock.

What's the current price of Stoke Therapeutics, Inc. Stock?
As of the end of day on the May 07, 2024, the price of an Stoke Therapeutics, Inc. (STOK) share was $11.94.

What is the 52-week high and low for Stoke Therapeutics, Inc. Stock?
The 52-week high for Stoke Therapeutics, Inc. Stock is $2.12 and the 52-week low is $0.650.

What is the market capitalization of Stoke Therapeutics, Inc. Stock?
As of the May 07, 2024, the market capitalization of Stoke Therapeutics, Inc. is 618.635M.

When is the next earnings date for Stoke Therapeutics, Inc.?
The upcoming earnings date for Stoke Therapeutics, Inc. is Aug 05, 2024.
Click to get the best stock tips daily for free!

About Stoke Therapeutics, Inc.

Stoke Therapeutics. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome,... STOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT